Shares

BHIM Positions Itself as ‘Bharat Ka Apna Payments App’ with New Campaign ‘Paison Ki Kadar’

BHIM Positions Itself as ‘Bharat Ka Apna Payments App’ with New Campaign ‘Paison Ki Kadar’

·         Conceptualised by Tilt Brand Solutions, the campaign features five brand films in 9 languages Chandigarh: BHIM, India’s homegrown payment app developed by NPCI BHIM Services Limited (NBSL), a wholly owned subsidiary of the National Payments Corporation of India (NPCI), has launched a new brand campaign to position itself as ‘Bharat Ka Apna Payments App’. The campaign titled ‘Paison Ki Kadar’, celebrates how India’s relationship with money is built on trust and familiarity, even as payment methods evolve. With this, BHIM reinforces its role as a modern and inclusive payments app, designed to serve the everyday payments needs of people…
Read More
Axis Bank introduces industry-first In-App Mobile OTP to enhance digital security

Axis Bank introduces industry-first In-App Mobile OTP to enhance digital security

#AxisBankMobileOTP Chandigarh: Axis Bank, one of the largest private sector banks in India, has introduced an industry-first ‘In-App Mobile OTP’ feature on its mobile app, ‘open’, to enhance authentication security and protect customers from rising OTP-related frauds and scams. This innovative feature eliminates dependence on telecom networks by generating time-based one-time passwords (TOTP) directly within the app, instead of sending OTPs via SMS. This ensures faster, more secure authentication while significantly reducing fraud risks. The Mobile OTP is a significant step in the bank’s overall fraud protection roadmap, as part of which it aims to introduce a series of initiatives…
Read More
Mahindra Aerostructures selected by Airbus for manufacturing H130 Helicopter Fuselage

Mahindra Aerostructures selected by Airbus for manufacturing H130 Helicopter Fuselage

#MahindraAerostructuresAirbusH130 A 'Make in India' Milestone Assemblies to be delivered to Airbus Helicopters' facility in Europe starting March 2027 Chandigarh: Mahindra Aerostructures Pvt. Ltd. (MASPL), a part of the Mahindra Group, has been awarded a prestigious contract by Airbus Helicopters to manufacture and assemble the main fuselage of its H130 light single-engine helicopter — marking a major milestone for India's ‘Make in India’ vision and further cementing Mahindra’s position as a trusted partner in the global aerospace supply chain. The contract was signed in the presence of Shri. Kinjarapu Rammohan Naidu, Honourable Minister of Civil Aviation, Government of India, Shri.…
Read More
Tata Steel Nederland announces major transformation programme to  enhance competitiveness for a sustainable future

Tata Steel Nederland announces major transformation programme to  enhance competitiveness for a sustainable future

#Tata SteelNederland Chandigarh: Tata Steel Nederland has today filed a Request for Advice to the Central Works Council to commence consultation on certain aspects of this transformation programme.  1.    Tata Steel’s steel making operations at IJmuiden in the Netherlands constitute one of the most strategically located steel plants in Europe with its own deep-sea port and proximity to key customers. The access to offshore wind energy, transmission and pipeline infrastructure will enable the transition to competitive green steel making for which intense engagement is ongoing with all stakeholders including the Dutch Government.  2.    In FY2025, the Netherlands operations have recovered…
Read More
Mahindra Delivers 3000 All-Electric Origin SUVs Across India

Mahindra Delivers 3000 All-Electric Origin SUVs Across India

#Mahindra3000SUV Chandigarh: Mahindra today announced a major milestone in its electric mobility journey, with over 3000 customer deliveries of its all-electric Origin SUVs—the XEV 9e and BE 6—completed since the commencement of deliveries on March 20, 2025. The response to Mahindra’s new electric SUV portfolio has been overwhelming. Both the XEV 9e and BE 6 continue to witness strong booking momentum, with majority of the customers opting for the fully loaded Pack Three variant. Current booking trends indicate 59% demand for the XEV 9e and 41% for the BE 6. The waiting period currently extends up to six months in…
Read More
U-Turn: Trump Offers 90-Day Tariff Relief to Allies, On China it goes Up to 125%

U-Turn: Trump Offers 90-Day Tariff Relief to Allies, On China it goes Up to 125%

#TrumpTariffReliefNotoChina Washington DC: In a dramatic shift in U.S. trade policy, President Donald Trump declared a 90-day pause on certain tariffs while simultaneously ramping up tariffs on Chinese imports to an unprecedented 125%, effective immediately. The announcement, made Wednesday via Trump’s Truth Social platform, marks another escalation in the former president’s long-standing trade battle with China. While details remain unclear on how the tariff pause will be administered, Trump stated, “I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately.” The ambiguous statement triggered sharp movements in global financial markets,…
Read More
IHCL EXPANDS PRESENCE IN UTTARAKHAND WITH THE SIGNING OF A GATEWAY HOTEL IN MUSSOORIE

IHCL EXPANDS PRESENCE IN UTTARAKHAND WITH THE SIGNING OF A GATEWAY HOTEL IN MUSSOORIE

#IHCLUTTARAKHANDMUSSOORIE Chandigarh: Indian Hotels Company (IHCL), India’s largest hospitality company, today announced the signing of a Gateway hotel in Mussoorie, Uttarakhand. This will be a conversion project. Ms. Suma Venkatesh, Executive Vice President – Real Estate & Development, IHCL, said, “Mussoorie is one of India’s most sought-after hill stations and its easy accessibility from key cities makes it an ideal getaway destination. With this signing we strengthen our presence in Uttarakhand, offering an itinerary of Haridwar, Dehradun and Mussoorie. We are delighted to partner with Mr. I.M. Garg, Mr. Gagan Garg and Mr. Gaurav Garg for this project.” Strategically located…
Read More
The RBI rate cut coupled with the revision in stance to accommodative was a swift: CS Setty, SBI

The RBI rate cut coupled with the revision in stance to accommodative was a swift: CS Setty, SBI

Chandigarh: C S Setty, State Bank of India Chairman, said on the RBI Monetary Policy - April 09, 2025“The RBI rate cut coupled with the revision in stance to accommodative was a swift, timely move and a forward guidance to the market to stay supportive against evolving global uncertainties. The revision of stance to accommodation will cushion the secondary impact of tariffs on domestic economy. With inflation under check, growth imperatives will take precedence in FY26." He Said that "On the regulation side market-based securitization framework for stressed assets, review of policy on gold lending and non-fund-based facility are timely.…
Read More
India is emerging as an oasis in a turbulent world: NSE MD & CEO Ashishkumar Chauhan

India is emerging as an oasis in a turbulent world: NSE MD & CEO Ashishkumar Chauhan

#NSEMDMUMBAINXT25 Chandigarh: Shri Ashishkumar Chauhan, MD & CEO of the National Stock Exchange of India (NSE), offered sharp insights into the Indian market's performance amidst global headwinds, investor sentiment, and future prospects. He shared views at the India Global Forum, Mumbai NXT25 Despite a $1.5 trillion dip from the peak, Chauhan emphasized the long-term growth trajectory of Indian capital markets. “In 2014, India’s market cap stood below $1 trillion. Today, it is nearing $5 trillion—demonstrating significant wealth creation,” he noted. Addressing concerns over foreign investor exits, Chauhan attributed the trend to global interest rate movements and a broader 'risk-off' sentiment…
Read More
Now Pharmaceutical Imports on Donald Trump Radar, ‘major’ tariffs on the Way

Now Pharmaceutical Imports on Donald Trump Radar, ‘major’ tariffs on the Way

#PharmaceuticalDonaldTrump Washington DC: US President Donald Trump, on Wednesday, said his administration would soon announce a “major” tariff on pharmaceutical imports, aimed at encouraging drug manufacturers to shift operations back to the US. Speaking at an event hosted by the National Republican Congressional Committee, Trump said the move is intended to reduce American dependence on foreign drug supplies and revitalise domestic pharmaceutical production. “We’re going to be doing something very big on drug imports — a major tariff is coming,” Trump told the audience. “We want these companies to make their products here, in America, not in China or elsewhere.” “Once…
Read More